New combo aims to boost breast cancer remission before surgery
Disease control
Not yet recruiting
This phase 3 trial tests whether a combination of sacituzumab govitecan (Trodelvy) and pembrolizumab (Keytruda) works better than standard chemotherapy before surgery for stage II-III triple-negative breast cancer. About 765 participants will be enrolled. The study aims to improv…
Phase: PHASE3 • Sponsor: Women's Cancer Study Group GmbH • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC